QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A phase I, randomized, double-blinded, single-dose study evaluating the pharmacokinetic equivalence of the biosimilar IBI305 and bevacizumab in healthy male subjects 期刊论文 INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2019, 卷号: 57, 期号: 3 作者:  Li, Cuiyun;  Zhang, Hong;  Zhu, Xiaoxue;  Wei, Haijing;  Chen, Hong 收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05 biosimilar  phase I  IBI305  bevacizumab  pharmacokinetics   Efficacy and safety of IBI305 compared with bevacizumab in advanced non-squamous NSCLC patients as first-line treatment in a randomized, double-blind, phase III study. 会议论文 作者:  Zhang, Li;  Wu, Bin;  Huang, Linian;  Shi, Meiqi;  Liu, Yunpeng 收藏  |  浏览/下载：20/0  |  提交时间：2019/12/05 Efficacy and safety of IBI305 compared with bevacizumab in advanced non-squamous NSCLC patients as first-line treatment in a randomized, double-blind, phase III study. 会议论文 作者:  Zhang, Li;  Wu, Bin;  Huang, Linian;  Shi, Meiqi;  Liu, Yunpeng 收藏  |  浏览/下载：12/0  |  提交时间：2019/12/05